Your browser doesn't support javascript.
loading
Use of mTOR inhibitor as prophylaxis for cytomegalovirus disease after kidney transplantation: A natural experiment.
Cristelli, Marina Pontelo; Felipe, Claudia Rosso; Prizmic, Paulo Sergio de Souza; de Azevedo, Vega Figueiredo Dourado; Viana, Laila Almeida; Tavares, Melissa Gaspar; Wagner de Castro Lima Santos, Daniel; de Paula, Mayara Ivani; Medina-Pestana, Jose Osmar; Tedesco-Silva Junior, Helio.
Afiliação
  • Cristelli MP; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Felipe CR; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Prizmic PSS; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • de Azevedo VFD; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Viana LA; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Tavares MG; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Wagner de Castro Lima Santos D; Infectious Disease Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • de Paula MI; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Medina-Pestana JO; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
  • Tedesco-Silva Junior H; Nephrology Division, Hospital do Rim, Federal University of São Paulo, São Paulo, SP, Brazil.
Clin Transplant ; 33(10): e13689, 2019 10.
Article em En | MEDLINE | ID: mdl-31400155
OBJECTIVES: To describe the incidence of cytomegalovirus (CMV) infection/disease in kidney transplant recipients receiving an mTOR-inhibitor-containing immunosuppressive regimen without prophylactic CMV treatment. METHODS: This single-center retrospective cohort analysis included all de novo kidney transplant recipients (09/15/2015-07/31/2017) receiving 3 mg/kg single dose of rabbit antithymocyte globulin induction, tacrolimus, everolimus, and prednisone. Preemptive therapy was initiated only in patients deemed at higher risk for CMV infection: (a) D+/R- CMV patients; (b) after treatment for acute rejection (ARt); and (c) after everolimus discontinuation (EVRd). RESULTS: Of 230 patients, there were no episodes of CMV disease among 217 (94%) without criteria to initiate preemptive therapy. Of 77 (33.5%) patients initiating preemptive therapy, 13 were D+/R-, 30 were ARt, and 34 were EVRd. The overall incidence of first CMV infection/disease was 6% (46.1% in D+/R-, 13.3% ARt [all patients had also discontinued everolimus], and 11.8% after early [<90 days] EVRd). The incidence of biopsy-proven acute rejection was 5.6%, and median glomerular filtration rate at month 12 was 47 mL/min/1.73m2 . One-year patient and death-censored graft survivals were 97.4% and 98.1%. CONCLUSION: This study suggests that everolimus-containing immunosuppressive regimen reduces the need for preventive strategies for CMV infection in the majority of kidney transplant recipients, reducing antiviral drug-associated toxicities and healthcare-related expenditures.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Infecções por Citomegalovirus / Citomegalovirus / Serina-Treonina Quinases TOR / Rejeição de Enxerto / Sobrevivência de Enxerto / Imunossupressores Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Dinamarca

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Rim / Infecções por Citomegalovirus / Citomegalovirus / Serina-Treonina Quinases TOR / Rejeição de Enxerto / Sobrevivência de Enxerto / Imunossupressores Tipo de estudo: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Brasil País de publicação: Dinamarca